A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.
|Articles|March 30, 2009
- Summer 2007
- Volume 6
- Issue 4
Fast Facts: Richard Roundtree
Fast facts about Richard Roundtree and his battle with breast cancer.
Advertisement
name >>
Richard Roundtree
........
occupation >>
Film, TV actor, Peabody-Award winner (for his narration of the PBS documentary The Rise and Fall of Jim Crow)
........
diagnosis >>
Stage 1 breast cancer (1993)
........
age at diagnosis >>
51 (younger than the average age of 60 for men with the disease; also, there was no family history of breast cancer)
........
treatment >>
Modified radical mastectomy, six months of chemotherapy
........
current status >>
Cancer-free
........
how cancer has affected his life >>
“I feel blessed to be a survivor. That’s why I talk about awareness. I want women and especially men to understand the importance of early detection and being in tune with your body. I want all cancer patients to have a good outcome.’’
Articles in this issue
about 17 years ago
How to Find Helpabout 17 years ago
Job Transitions, Insurance Changeabout 17 years ago
Medicare Coverage for Colon Cancer Screeningsabout 17 years ago
Noting Group Differencesover 17 years ago
The Journey of Cancer Survivorshipover 17 years ago
Beauty Shoppingover 17 years ago
Pregnancy After Cancerover 19 years ago
Portal Authorityover 19 years ago
Precious Tumorover 19 years ago
Surviving "Survivor" StereotypesAdvertisement
Related to this article
She was diagnosed with stage 4 primary mediastinal B-cell lymphoma (PMBCL), a type of non-Hodgkin lymphoma that starts in the center of the chest, at 29.
Jyoti Malhotra, MD, MPH on first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to Yale Cancer Center.
Dr. Maureen McEvoy explains breast cancer surgery options, reconstruction, recovery and how to close gaps in access to care.
For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
A cancer survivor reflects on losing her hair during chemotherapy, the emotional impact of hair loss and what growing it back taught her about healing, identity and life.
After a lung cancer diagnosis, one Bronx writer reflects on faith, survivorship and learning that healing isn't a finish line, but a daily journey.
Dr. David DiBardino explains how intratumoral therapy is being studied to deliver treatment directly into tumors and potentially enhance radiation in patients with locally advanced non-small cell lung cancer.
Advertisement
Advertisement
Trending on CURE
1
Expert Says Blood Cancer Care Is Moving Past Chemotherapy
2
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
3
We Eat Bagels Before Cancer Treatment. Here’s Why.
4
A Breast Surgeon Explains Lumpectomy, Mastectomy and Recovery
5